$28.550
+0.051 (+0.18%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
LKFT 相似图表分析预测
Alphio's LKFT stock price prediction model matches the current Lakefront Biotherapeutics NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $28.02 (-1.86%). The 1-week path is $28.19 (-1.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Lakefront Biotherapeutics NV 股票吗?
Lakefront Biotherapeutics appears to be a good buy right now due to its recent positive developments and favorable financial metrics. The current price is $28.88, which is below the analyst's revised price target of $26, indicating potential upside. The company has a strong gross margin of 99.95% reported in Q4 2025, and its recent FDA Orphan Drug Designation for Gamgertamig enhances its market potential. However, the main risk is the high forward P/E ratio of 344.83, indicating that the stock may be overvalued if growth does not materialize as expected.
LKFT 股价于 Tuesday 收于 $28.55,此前上涨 +0.18%
Lakefront Biotherapeutics NV (LKFT) last closed at $28.55, gaining +0.18%. These facts feed the 1-day and 1-week LKFT price prediction above.
预测驱动因素
Lakefront Biotherapeutics NV(LKFT)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似图表形态
近期走势与 LKFT 最接近的股票,按相似度排序。
LKFT 季节性分析
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。